University of Alabama at Birmingham is a clinical research site located in Huntsville, Alabama, United States 35801.
Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.
University of Alabama at Birmingham has participated in 3 clinical trials.
Therapeutic areas: Treatment Resistant Depression, Generalized Anxiety Disorder, Epilepsy.
Sponsors: Denovo Biopharma LLC, Otsuka Pharmaceutical Development & Commercialization, Inc., Lundbeck LLC.
Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Alabama at Birmingham has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Alabama at Birmingham has 3 clinical trials on record. Their work covers Treatment Resistant Depression, Generalized Anxiety Disorder, Epilepsy.
University of Alabama at Birmingham has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.